Adult hippocampal neurogenesis-associated memory performance in people with Parkinson’s disease with and without cognitive impairment
Objective: To evaluate the role of adult hippocampal neurogenesis (AHN)-associated memory measures to the cognitive performance of people with Parkinson’s disease (PwP) with or without…Cognitive Function in Late-life and Parkinson’s Disease Neuropathology at Death
Objective: To examine the association between cognitive function in late-life and Parkinson’s disease (PD) neuropathology at death, including 1) neuron loss in the locus coeruleus…Evolution of biochemical and clinical signature of GBA-related Parkinson’s Disease: a 2-year longitudinal study
Objective: To evaluate peripheral biochemical markers as well as clinical features of GBA-related Parkinson’s Disease (GBA-PD) subjects over a 2-year follow-up in comparison with NM-PD…HAB-C murine model present reactive adult neurogenesis and astrogliosis in adult brain
Objective: To analyze the adult neurogenic response to a neurodegenerative process due to H-ABC tubulinopathy. Background: H-ABC is a neurodegenerative disease caused by mutations in…Correlation between H-ABC and thyroid hormones signaling in the process of adult neurogenesis
Objective: To analyze a possible correlation between the TH signaling and cellular fate of adult neural stem cells on taiep rats. Background: H-ABC is a…NUS1 polymorphisms modify the risk and age at onset of Parkinson’s disease
Objective: In this study, using whole-exome sequencing (WES) and direct Sanger sequencing analysis, we investigated the common and low-frequency variants of NUS1 in two case-control…Association of Interleukin (IL)-2 and IL2RA gene polymorphisms with Parkinson’s disease in Taiwan
Objective: The purpose of this study is to investigate if interleukin 2 (IL-2) and interleukin 2 receptor alpha (IL2RA) genes are associated with Parkinson’s disease…Early predictors of Parkinson’s disease and prognosis in relatives
Objective: To study early clinical and biochemical markers of Parkinson's disease (PD) in relatives of Uzbek nationality. Background: Parkinson's disease is a neurodegenerative hereditary disease…Parkinson’s Foundation Physical Therapy Faculty Program Evaluation
Objective: In 2016, the Parkinson’s Foundation partnered with clinical and research experts to implement a training program for physical therapy (PT) faculty who want to…Contribution of coding/noncoding variants in NUS1 to late-onset sporadic Parkinson’s disease
Objective: Here, we designed a case-control study to analyze WGS variants in NUS1 coding regions and NUS1 related non-coding regions to investigate the relative contribution…